NINDS Neuroscience Funding Announcements

Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

Notice of Intent to Issue an FOA (RFA) to Continue the Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers Program
Release Date: February 8, 2007
Announcement Number: NOT-NS-07-005

Funding Contact: John Porter, Ph.D.
Program Area: Channels, Synapses and Neural Circuits

Brief Description:
The National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) , the National Institute of Child Health and Human Development (NICHD), and the National Heart, Lung, and Blood Institute (NHLBI) intend to issue an RFA for new (type 1) or competitive renewal (type 2) applications for the support of Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (Wellstone MDCRCs). The Wellstone MDCRCs funded through this program have contributed toward the goal of improving the detection, diagnosis, treatment, and prevention of the muscular dystrophies. The initial three Wellstone MDCRCs were funded in 2003. The RFA to continue the Wellstone MDCRCs is expected to be published in the Spring of 2007 with applications using the U54 Specialized Center—Cooperative Agreement mechanism due in the Fall of 2007.

Choose an option to view additional funding announcements